Litigation Details for iCeutica Pty Ltd v. Lupin Limited (D. Maryland 2017)
✉ Email this page to a colleague
iCeutica Pty Ltd v. Lupin Limited (D. Maryland 2017)
| Docket | ⤷ Sign Up | Date Filed | 2017-02-10 |
| Court | District Court, D. Maryland | Date Terminated | |
| Cause | 35:271 Patent Infringement | Assigned To | Marvin J. Garbis |
| Jury Demand | Plaintiff | Referred To | |
| Patents | 9,526,734; 9,649,318 | ||
| Link to Docket | External link to docket | ||
Small Molecule Drugs cited in iCeutica Pty Ltd v. Lupin Limited
The small molecule drug covered by the patents cited in this case is ⤷ Sign Up .
Details for iCeutica Pty Ltd v. Lupin Limited (D. Maryland 2017)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 2018-02-01 | 96 | United States Patent Nos. 9,526,734 (“the ‘734 patent”) and 9,649,318 (“the 318 patent”)(collectively…independent claims of the ‘734 patent and in three independent claims of the ‘318 patent. A representative claim… “It is a bedrock principle of patent law that the claims of a patent define the invention to which the…The applicable claims of the Patents-in-Suit limit the scope of the patent to an accused dose by reference…fasted state” or “fed state.”9 ‘734 Patent 25:38. 8 See ‘734 patent at 2:17-24, 2:53-58, 2:53-3:12, | External link to document | |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
